Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression.
BACKGROUND
Ketamine, a widely used intravenous anesthetic agent, is biotransformed by cytochrome P450s (CYPs). Considerable attention is devoted to the ketamine-involved regulation of CYP gene expression. Assessing how ketamine regulates CYP gene expression is significant in recognizing the pharmacology of this anesthetic agent and its clinical application.


METHODS
In this review, the authors discuss the effects of ketamine on the regulation of CYP gene expression and its possible mechanisms from the aspects of cytoskeletal remodeling, mitochondrial dysfunction, and alterations of intracellular ATP levels and calcium homeostasis.


RESULTS
This review may provide readers with more clues for recognizing and avoiding possible ketamine-drug interactions.


CONCLUSIONS
Ketamine may inhibit CYP3A4 expression possibly through reducing calcium mobilization and mitochondrial ATP synthesis and consequently disturbing cytoskeleton remodeling.
Chen
Jui-Tai
JT
Taipei Medical University-Wan Fang Hospital, Department of Anesthesiology, Taipei, Taiwan.
Chen
Ruei-Ming
RM
D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis* / Q000235:genetics*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D006801:Humans; D007649:Ketamine / Q000378:metabolism / Q000494:pharmacology*
D007649:Ketamine; D003577:Cytochrome P-450 Enzyme System